[Federal Register: August 8, 2006 (Volume 71, Number 152)]
[Notices]
[Page 45057]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr08au06-66]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Science Advisory Board to the National Center for Toxicological
Research; Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). At least one
portion of the meeting will be closed to the public.
Name of Committee: Science Advisory Board (SAB) to the National
Center for Toxicological Research (NCTR).
General Function of the Committee: The Board advises the Director,
NCTR, in establishing, implementing, and evaluating the research
programs that assist the Commissioner of Food and Drugs in fulfilling
his regulatory responsibilities. The Board provides an extra-agency
review in ensuring that the research programs at NCTR are
scientifically sound and pertinent.
Date and Time: The meeting will be held on August 29, 2006 from
8:30 a.m. to 4:30 p.m. and on August 30, 2006, from 8 a.m. to 12 noon.
Location: August 29, 2006: NCTR SAB Conference Room B-12, 3900 NCTR
Dr., Jefferson, AR 72079. August 30, 2006: University of Arkansas for
Medical Sciences, Stephens Spine Center, Hamlin Board Room, 501 Jack
Stephens Dr., Little Rock, AR 72205.
Contact Person: Leonard Schechtman, Executive Secretary, National
Center for Toxicological Research, Food and Drug Administration, 5600
Fishers Lane, rm. 16-85, Rockville, MD 20857, 301-827-6696, or FDA
Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in
the Washington, DC area), code 3014512559. Please call the Information
Line for up-to-date information on this meeting.
Agenda: On August 29, 2006, the SAB will hear presentations from
the NCTR Divisions that will update them on ongoing research
activities. The SAB will be presented with a response to the evaluation
of the Division of Neurotoxicology. The evaluation was the product of a
site visit team that conducted an on-site review of the Division in
January 2004. The response will address the issues raised and
recommendations made by the site visit team. On August 30, 2006, the
NCTR Director will provide a Center-wide update on scientific endeavors
and will discuss the NCTR realignment and strategic focus.
Procedure: On August 29, 2006, from 8:30 a.m. to 4:30 p.m., and
August 30, 2006, from 8 a.m. to 10:30 a.m., the meeting is open to the
public. Interested persons may present data, information, or views,
orally or in writing, on issues pending before the committee. Written
submissions may be made to the contact person on or before August 14,
2006. Oral presentations from the public will be scheduled on August
29, 2006, between approximately 12:30 p.m. to 1:30 p.m. Time allotted
for each presentation may be limited. Those desiring to make formal
oral presentations should likewise notify the contact person and submit
a brief statement of the general nature of the evidence or arguments
they wish to present, the names and addresses of proposed participants,
and an indication of the approximate time requested to make their
presentation on or before August 14, 2006.
Closed Committee Deliberations: On August 29, 2006, from
approximately 11 a.m. to 12:30 p.m., the meeting will be closed to
permit discussion where disclosure would constitute a clearly
unwarranted invasion of personal privacy (5 U.S.C. 552b(c)(6)). This
portion of the meeting will be closed to permit discussion of
information concerning individuals associated with the research
programs at NCTR.
Persons attending FDA's advisory committee meetings are advised
that the agency is not responsible for providing access to electrical
outlets.
FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
physical disabilities or special needs. If you require special
accommodations due to a disability, please contact the office of the
Executive Secretary at least 7 days in advance of the meeting.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: August 2, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6-12863 Filed 8-7-06; 8:45 am]
BILLING CODE 4160-01-S